T. Rowe Price Associates
HR icon

T. Rowe Price Associates’s Healthcare Realty HR Stock Holding History

T. Rowe Price Associates’s Portfolio HR Stock Details HR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$272M Buy
16,001,233
+1,022,482
+7% +$17.9M 0.03% 384
2025
Q4 		$254M Sell
14,978,751
-347,293
-2% -$6.18M 0.03% 394
2025
Q3 		$276M Buy
15,326,044
+14,388,480
+1,535% +$243M 0.03% 383
2025
Q2 		$14.9M Buy
937,564
+701,854
+298% +$10.7M ﹤0.01% 1032
2025
Q1 		$3.98M Buy
235,710
+4,338
+2% +$72.1K ﹤0.01% 1317
2024
Q4 		$3.92M Sell
231,372
-198,372
-46% -$3.49M ﹤0.01% 1357
2024
Q3 		$7.8M Sell
429,744
-2,903,846
-87% -$51.5M ﹤0.01% 1187
2024
Q2 		$54.9M Sell
3,333,590
-2,448,663
-42% -$37.5M 0.01% 693
2024
Q1 		$81.8M Buy
5,782,253
+158,342
+3% +$2.39M 0.01% 592
2023
Q4 		$96.9M Sell
5,623,911
-82,858
-1% -$1.27M 0.01% 554
2023
Q3 		$87.1M Buy
5,706,769
+1,374,894
+32% +$24.4M 0.01% 536
2023
Q2 		$81.7M Buy
4,331,875
+1,312,402
+43% +$25.3M 0.01% 573
2023
Q1 		$58.4M Buy
3,019,473
+2,871,686
+1,943% +$57.9M 0.01% 643
2022
Q4 		$2.85M Sell
147,787
-7,126
-5% -$140K ﹤0.01% 1345
2022
Q3 		$3.23M Sell
154,913
-1,785,899
-92% -$45.4M ﹤0.01% 1293
2022
Q2 		$54.2M Buy
1,940,812
+146,372
+8% +$4.35M 0.01% 850
2022
Q1 		$56.2M Sell
1,794,440
-84,544
-4% -$2.66M 0.01% 930
2021
Q4 		$62.7M Buy
1,878,984
+17,371
+0.9% +$580K 0.01% 921
2021
Q3 		$55.2M Sell
1,861,613
-44,292
-2% -$1.29M 0.01% 972
2021
Q2 		$50.9M Buy
1,905,905
+41,463
+2% +$1.17M ﹤0.01% 1021
2021
Q1 		$51.4M Buy
1,864,442
+45,852
+3% +$1.28M 0.01% 994
2020
Q4 		$50.1M Sell
1,818,590
-940,281
-34% -$24.8M 0.01% 963
2020
Q3 		$71.7M Sell
2,758,871
-364,552
-12% -$9.57M 0.01% 758
2020
Q2 		$82.8M Sell
3,123,423
-170,245
-5% -$4.36M 0.01% 690
2020
Q1 		$80M Sell
3,293,668
-1,167,403
-26% -$35.3M 0.01% 641
2019
Q4 		$135M Sell
4,461,071
-79,125
-2% -$2.36M 0.02% 573
2019
Q3 		$133M Sell
4,540,196
-304,577
-6% -$8.51M 0.02% 536
2019
Q2 		$133M Buy
4,844,773
+4,741,860
+4,608% +$134M 0.02% 574
2019
Q1 		$2.94M Buy
102,913
+1,700
+2% +$47.3K ﹤0.01% 1488
2018
Q4 		$2.56M Buy
101,213
+24,241
+31% +$642K ﹤0.01% 1499
2018
Q3 		$2.05M Buy
76,972
+1,467
+2% +$40.4K ﹤0.01% 1611
2018
Q2 		$2.04M Buy
75,505
+327
+0.4% +$8.32K ﹤0.01% 1591
2018
Q1 		$1.99M Buy
75,178
+8,925
+13% +$238K ﹤0.01% 1577
2017
Q4 		$1.99M Buy
66,253
+17,970
+37% +$544K ﹤0.01% 1586
2017
Q3 		$1.44M Buy
48,283
+26
+0.1% +$790 ﹤0.01% 1657
2017
Q2 		$1.5M Buy
48,257
+3,728
+8% +$118K ﹤0.01% 1630
2017
Q1 		$1.4M Buy
44,529
+9
+0% +$273 ﹤0.01% 1678
2016
Q4 		$1.3M Buy
44,520
+10
+0% +$294 ﹤0.01% 1691
2016
Q3 		$1.45M Hold
44,510
– – ﹤0.01% 1622
2016
Q2 		$1.44M Sell
44,510
-4
-0% -$120 ﹤0.01% 1606
2016
Q1 		$1.31M Buy
44,514
+9,260
+26% +$257K ﹤0.01% 1633
2015
Q4 		$951K Buy
35,254
+254
+0.7% +$6.55K ﹤0.01% 1710
2015
Q3 		$858K Buy
35,000
+12,400
+55% +$306K ﹤0.01% 1752
2015
Q2 		$541K Hold
22,600
– – ﹤0.01% 1961
2015
Q1 		$630K Hold
22,600
– – ﹤0.01% 1887
2014
Q4 		$609K Hold
22,600
– – ﹤0.01% 1878
2014
Q3 		$524K Hold
22,600
– – ﹤0.01% 1916
2014
Q2 		$544K Buy
22,600
+7,850
+53% +$187K ﹤0.01% 1914
2014
Q1 		$336K Hold
14,750
– – ﹤0.01% 2110
2013
Q4 		$290K Buy
+14,750
New +$313K ﹤0.01% 2154

Other funds holding HR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
Resolution Capital Sydney, NSW, Australia $4.76B AUM 10.22% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates's HR Position: Q1 2026 in Review

T. Rowe Price Associates increased its Healthcare Realty (HR) stake by 6.8% in Q1 2026, buying an estimated $17.9M and bringing the position to 16,001,233 shares worth $272M. The position accounts for 0.03% of the portfolio, ranked #384.

T. Rowe Price Associates first reported a position in HR in Q4 2013 and has held it in 50 quarters since. The position peaked at $276M in Q3 2025. 445 funds tracked by Wall St. Rank hold HR as of Q1 2026.

  • T. Rowe Price Associates held 16,001,233 shares of Healthcare Realty worth $272M as of Q1 2026.
  • T. Rowe Price Associates bought 1,022,482 Healthcare Realty shares in Q1 2026, an estimated $17.9M.
  • Healthcare Realty made up 0.03% of T. Rowe Price Associates's portfolio in Q1 2026, its #384 holding.
  • T. Rowe Price Associates first reported a position in Healthcare Realty in Q4 2013 and has held it in 50 quarters since.
  • T. Rowe Price Associates's Healthcare Realty position peaked at $276M in Q3 2025.
  • 445 funds tracked by Wall St. Rank held Healthcare Realty as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.